Provenienza dei contatti di primo grado di Charlotte Parry
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Investment Managers | 23 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Charlotte Parry tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SMITH & NEPHEW PLC | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Ramot at Tel Aviv University Ltd.
 Ramot at Tel Aviv University Ltd. Miscellaneous Commercial ServicesCommercial Services Ramot at Tel Aviv University Ltd. operates as a technology transfer company of Tel Aviv University (TAU). It provides legal and commercial frameworks for inventions made by TAU faculty, students, and researchers. The firm licenses the university's intellectual property to third parties through agreements; facilitates collaborative research partnerships between business partners and TAU researchers; establishes a company; and forms joint ventures that promote TAU technologies. The company was founded in 1973 and is headquartered in Tel Aviv, Israel. | Miscellaneous Commercial Services | Chief Executive Officer | |
| ABCAM PLC | Biotechnology | Director/Board Member | |
| Tel Aviv University Economic Corp. Ltd. | Chief Executive Officer | ||
| AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
eXIthera Pharmaceuticals, Inc.
 eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA. | Biotechnology | Director/Board Member | |
| BELLEROPHON THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Chief Tech/Sci/R&D Officer | |
| HALMA PLC | Electronic Equipment/Instruments | Director/Board Member | |
| University of Oxford | College/University | Director of Finance/CFO Graduate Degree Undergraduate Degree | |
| Imperial College London | College/University | Masters Business Admin Undergraduate Degree | |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Financial Conglomerates | Director/Board Member | |
Gartner Research Group
 Gartner Research Group Investment Banks/BrokersFinance Gartner Research Group provides risk management, business marketing and computer software information services. The company is headquartered in Stamford, CT. | Investment Banks/Brokers | President | |
Pappas Capital LLC
 Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Investment Managers | Chief Executive Officer Consultant / Advisor | |
| ALLON THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| Universität zu Köln | College/University | Doctorate Degree | |
| University College London | College/University | Doctorate Degree Doctorate Degree | |
| CYCLACEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| ACACIA RESEARCH CORPORATION | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Coley Pharmaceutical GmbH
 Coley Pharmaceutical GmbH Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Coley Pharmaceutical GmbH is a German company that provides research and development in the field of natural sciences, engineering, agricultural sciences and medicine. The company is based in Berlin, Germany. The company was founded by Heather L. Davis. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Office of Technology Development
 Office of Technology Development Investment ManagersFinance Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Chief Tech/Sci/R&D Officer | |
Quanta Dialysis Technologies Ltd.
 Quanta Dialysis Technologies Ltd. Medical SpecialtiesHealth Technology Quanta Dialysis Technologies Ltd. develops haemodialysis systems. The firm's SC+ is a performance, portable, compact haemodialysis system providing clinical efficacy utilising flow rates typically used on traditional machines. It offers SelfCare+, a haemodialysis machine for dialysis patients to control their disease and determine the treatment regime and care. The company was founded by Clive Henrey Buckberry, John Eric Milad and Martin Johnson in 2008 and is headquartered in Alcester, the United Kingdom. | Medical Specialties | Director/Board Member Director/Board Member | |
| Arthur Anderson & Co. | Corporate Officer/Principal | ||
Biogen Idec Ltd.
 Biogen Idec Ltd. BiotechnologyHealth Technology Biogen Idec Ltd. develops therapies for neurodegenerative, haematologic, and autoimmune disorders. The firm develops treatment for Alzheimer’s Disease, spinal muscular atrophy, lupus, and amyotrophic lateral sclerosis (ALS), amongst others. The company was founded on 2003 and is headquartered in Maidenhead, the United Kingdom. | Biotechnology | Corporate Officer/Principal | |
Yeda Research & Development Co. Ltd.
 Yeda Research & Development Co. Ltd. Investment ManagersFinance Yeda Research & Development Co. Ltd. engages in development of natural science and services. It covers broad of spectrum including: biotechnology, pharmaceuticals and diagnostics, bioinformatics, proteomics, biomatics and system biology, medical devices, renewable energy, bio fuels, clean technology and environmental sciences, agricultural and plants genetics, chemistry and nanotechnology, physics and electro-optics, mathematics and computer science. The company is headquartered in Rehovot, Israel. | Investment Managers | Chief Executive Officer | |
BIO Deutschland
 BIO Deutschland Miscellaneous Commercial ServicesCommercial Services BIO Deutschland is a business association for the biotechnology industry. The private company is based in Berlin, Germany. The German company was founded by Peter Heinrich, Horst Domdey. Viola Bronsema has been the CEO of the company since 2006. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Kellogg School of Management | College/University | Masters Business Admin | |
OMEICOS Therapeutics GmbH
 OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany. | Biotechnology | Director/Board Member | |
LetterOne Holdings SA
 LetterOne Holdings SA Investment ManagersFinance LetterOne Holdings SA (L1) is an independent private equity firm headquartered in Luxembourg, Luxembourg. The firm was founded in 2013 by Mikhail Fridman. | Investment Managers | Chief Executive Officer Director/Board Member | |
Rigontec GmbH
 Rigontec GmbH Pharmaceuticals: MajorHealth Technology Rigontec GmbH provides RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The firm develops a compound stimulating the immune receptor retinoic acid-inducible gene. The company was founded by Annegret de Baey-Diepolder, Gunther Hartmann, Anna Schwickart, Marcel Renn, Christine Schuberth-Wagner and Veit Hornung in 2014 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
Open House London Ltd.
 Open House London Ltd. RestaurantsConsumer Services Open House London Ltd. was founded in 2013 and operates restaurants. The non-profit company is based in London, UK. | Restaurants | Chairman | |
| UCL Medical School | College/University | Doctorate Degree | |
| Eclosion2 & Cie Scpc | Director/Board Member | ||
New York University Medical Center
 New York University Medical Center Other Consumer ServicesConsumer Services Part of New York University, New York University Medical Center is a healthcare provider that offers personalized treatment for reproductive and sexual health conditions in men and women. The company is based in New York and provides emergency and urgent care at various locations, as well as Virtual Urgent Care. NYU Langone's Community Health Needs Assessment and Service Plan aims to support behavior change and disease prevention at the neighborhood level. The American company was founded by J. Ira Harris. | Other Consumer Services | Corporate Officer/Principal | |
Depixus SAS
 Depixus SAS Miscellaneous Commercial ServicesCommercial Services Depixus SAS is a life science technology company based in Paris, France. Depixus is pioneering ground-breaking magna™ technology based on magnetic force spectroscopy, revealing dramatic new insights into complex biomolecular interactions at the single molecule level. The French company was founded by Gordon Hamilton and has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
STipe Therapeutics ApS
 STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Twelve Bio
 Twelve Bio Miscellaneous Commercial ServicesCommercial Services Part of Ensoma, Inc., Twelve Bio is a Danish company that seeks to expand the breadth of CRISPR-based gene-editing medicines to transform the management of serious diseases. The company is based in Copenhagen, Denmark. Twelve Bio uses its insights into nuclease structure and function to design highly precise and nimble CRISPR-Cas12 candidates for therapeutic application. The company will continuously advance its platform and understanding of Cas enzymes to address the needs of patients worldwide. The company was founded by Stefano Stella, Guillermo Montoya. Twelve Bio was acquired by Ensoma, Inc. on February 09, 2023. | Miscellaneous Commercial Services | Chairman | |
Arix Bioscience /Venture Capital/
 Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience /Venture Capital/ (Arix Bioscience) is a venture capital subsidiary of Arix Bioscience Plc founded in 2015 by Christopher Thomas Evans, Jonathan M. Peacock and Joseph Anderson. The firm is headquartered in London, United Kingdom with an additional offices in New York. | Investment Managers | Director/Board Member Director/Board Member Private Equity Investor Chairman | |
Neovii Biotech GmbH
 Neovii Biotech GmbH BiotechnologyHealth Technology Neovii Biotech GmbH develops and markets biopharmaceutical products in the field of transplantation. The company was founded in 2003 and is headquartered in Gräfelfing, Germany. | Biotechnology | Chief Executive Officer | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 18 |
| Regno Unito | 16 |
| Germania | 7 |
| Israele | 5 |
| Francia | 3 |
Settori
| Health Technology | 21 |
| Consumer Services | 11 |
| Commercial Services | 9 |
| Finance | 9 |
| Electronic Technology | 2 |
Posizioni
| Director/Board Member | 234 |
| Independent Dir/Board Member | 69 |
| Chairman | 67 |
| Corporate Officer/Principal | 67 |
| Director of Finance/CFO | 17 |
Contatti più connessi
| Insiders | |
|---|---|
| David C. U'Prichard | 49 |
| Franz Humer | 45 |
| Art Pappas | 42 |
| Trevor Jones | 36 |
| Meghan Fitzgerald | 28 |
| Mark Chin | 25 |
| Maureen O'Connell | 24 |
| John Banham | 23 |
| Isaac Kohlberg | 20 |
| Jonathan Leslie Tobin | 19 |
| Peregrine Moncreiffe | 18 |
| Giles Kerr | 16 |
| John Matthew Patrick Hutton | 15 |
| James Rawlingson | 14 |
| Michael William Bunbury | 13 |
- Borsa valori
- Insiders
- Charlotte Parry
- Connessioni Società
